The findings underscore the need to treat heart failure with urgency and double down on clinician education, one expert says.

Approximately one in four patients died, deteriorated to a higher shock stage, or were transferred for a higher level of care ...

Individuals assigned male at birth who were pushed to change their identity had more inflammation and higher blood pressure.

The novel CETP inhibitor, once tested for the now-defunct pathway of HDL raising, reduces LDL as well as Lp(a).

By group, procedural success and freedom from LVOT obstruction (LVOT mean gradient > 50 mm Hg), the primary efficacy endpoint ...

Telling patients how many extra days they’ll be free from an event can help with shared decision-making, experts say.

TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting the next wave of innovation in research and education that will help doctors save and improve the ...

Michael Mack speaks to Allan Schwartz, a principal investigator of the EARLY TAVR trial, who explains how it informs patient management.